These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9389063)

  • 21. Apical rotation assessed by speckle-tracking echocardiography as an index of global left ventricular contractility.
    Kim WJ; Lee BH; Kim YJ; Kang JH; Jung YJ; Song JM; Kang DH; Song JK
    Circ Cardiovasc Imaging; 2009 Mar; 2(2):123-31. PubMed ID: 19808578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a method to correct the contractility index LVdP/dt(max) for changes in heart rate.
    Markert M; Trautmann T; Groß M; Ege A; Mayer K; Guth B
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):98-105. PubMed ID: 22554385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vesnarinone restores contractility and calcium handling in early endotoxemia.
    Takeuchi K; del Nido PJ; Poutias DN; Cowan DB; Munakata M; McGowan FX
    Circulation; 2000 Nov; 102(19 Suppl 3):III365-9. PubMed ID: 11082415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
    Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy.
    Kass DA; Van Anden E; Becker LC; Kasper EK; White WB; Feldman AM
    Am J Cardiol; 1996 Sep; 78(6):652-6. PubMed ID: 8831399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL; Gaide MS; Lodge NJ; Cameron JS
    Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
    Joho S; Asanoi H; Ishizaka S; Kameyama T; Inoue H
    J Card Fail; 2002 Dec; 8(6):423-30. PubMed ID: 12528096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
    Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
    Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744).
    Micheletti R; Mattera GG; Rocchetti M; Schiavone A; Loi MF; Zaza A; Gagnol RJ; De Munari S; Melloni P; Carminati P; Bianchi G; Ferrari P
    J Pharmacol Exp Ther; 2002 Nov; 303(2):592-600. PubMed ID: 12388640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias.
    Wu Z; Awaji T; Abe H; Motomura S; Hashimoto K
    Jpn J Pharmacol; 1993 Nov; 63(3):399-404. PubMed ID: 8107332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
    Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
    Exp Hematol; 1996 Jan; 24(1):37-42. PubMed ID: 8536790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
    Abe Y; Kitada Y; Narimatsu A
    J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
    Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
    Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on positive inotropic agents. I. Synthesis of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone and related compounds.
    Tominaga M; Yo E; Ogawa H; Yamashita S; Yabuuchi Y; Nakagawa K
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2100-10. PubMed ID: 6488396
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Features of contraction of various sections of the left ventricle of an intact heart upon the action of inotropic factors].
    Chernysh AM; Farber FE
    Fiziol Zh SSSR Im I M Sechenova; 1989 Apr; 75(4):529-35. PubMed ID: 2759290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog.
    Grupp G; Grupp IL; Newman G; Schwartz A
    Arzneimittelforschung; 1984; 34(3A):359-63. PubMed ID: 6540089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.